Denosumab-Associated Osteonecrosis of the Jaw: FDG PET/CT Findings in a Case Report
DOI:
https://doi.org/10.59667/sjoranm.v13i1.18Keywords:
MANDIBLE, DENOSUMAB, OSTEONECROSIS, FDG PET/CTAbstract
A 77-year-old woman with stage IV non-small cell lung cancer receiving denosumab for the prevention of skeletal-related events presented with two months of worsening jaw pain and swelling accompanied by low-grade fever. FDG PET/CT demonstrated increased uptake in the left mandible with cortical thickening, marrow sclerosis and surrounding soft-tissue thickening and oedema. Osteonecrosis of the jaw was suspected in the clinical context and subsequently confirmed by an oral surgeon. Conservative treatment comprised antibiotics, oral hygiene measures and pain management. This case illustrates the metabolic and structural findings of jaw osteonecrosis during denosumab therapy. FDG uptake is nonspecific and requires correlation with clinical findings and structural imaging.
References
Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci. 2011;1218(1):38–46. https://doi.org/10.1111/j.1749-6632.2010.05768.x DOI: https://doi.org/10.1111/j.1749-6632.2010.05768.x
Marx RE. A Decade of Bisphosphonate Bone Complications: What It Has Taught Us About Bone Physiology. Int J Oral Maxillofac Implants. 2014;29(2):247. https://doi.org/10.11607/jomi.te61 DOI: https://doi.org/10.11607/jomi.te61
Glaudemans A, et al. The Use of 18F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases. J Immunol Res. 2013;2013:623036. https://doi.org/10.1155/2013/623036 DOI: https://doi.org/10.1155/2013/623036
Dinnoo A, et al. 18F-FDG PET/CT for early response assessment of jaw osteoradionecrosis after the PENTOCLO protocol: A promising imaging modality. J Stomatol Oral Maxillofac Surg. 2022;123(4):e192–e198. https://doi.org/10.1016/j.jormas.2021.11.005 DOI: https://doi.org/10.1016/j.jormas.2021.11.005
Downloads
Published
Issue
Section
License
Copyright (c) 2024 SALONI RAJKOTIA, RITESH SUTHAR, ABHISHEK PALSAPURE

This work is licensed under a Creative Commons Attribution 4.0 International License.
This license requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, even for commercial purposes.